The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19.

MLA

Evans, Daniel, et al. “The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19.” Clinical Chemistry, vol. 68, no. 1, Jan. 2022, pp. 153–62. EBSCOhost, https://doi.org/10.1093/clinchem/hvab219.

APA

Evans, D., Cowen, S., Kammel, M., O’Sullivan, D. M., Stewart, G., Grunert, H.-P., Moran-Gilad, J., Verwilt, J., Jiwon In, Vandesompele, J., Harris, K., Ki Ho Hong, Storey, N., Hingley-Wilson, S., Dühring, U., Young-Kyung Bae, Foy, C. A., Braybrook, J., Zeichhardt, H., & Huggett, J. F. (2022). The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19. Clinical Chemistry, 68(1), 153–162. https://doi.org/10.1093/clinchem/hvab219

Chicago

Evans, Daniel, Simon Cowen, Martin Kammel, Denise M. O’Sullivan, Graham Stewart, Hans-Peter Grunert, Jacob Moran-Gilad, et al. 2022. “The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19.” Clinical Chemistry 68 (1): 153–62. doi:10.1093/clinchem/hvab219.